[Federal Register: May 25, 1999 (Volume 64, Number 100)]
[Notices]               
[Page 28214-28215]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25my99-106]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 23, 1999, Research 
Triangle Institute, Kenneth H. Davis, Jr., Hermann Building, East 
Institute Drive, PO Box 12194, Research Triangle Park, North Carolina 
27709, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Cocaine (9041).............................  II
------------------------------------------------------------------------


[[Page 28215]]

    The institute will manufacture marihuana cigarettes for the 
National Institute on Drug Abuse (NIDA) and the cocaine will be used 
for reference standards, human and animal research, as dictated by 
NIDA.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than July 26, 1999.

    Dated: May 12, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-13094 Filed 5-24-99; 8:45 am]
BILLING CODE 4410-09-M